Acute renal insufficiency, supraventricular tachycardia, and confusion after recombinant human bone morphogenetic protein-2 implantation for lumbosacral spine fusion.
暂无分享,去创建一个
[1] Dong Liu,et al. Bone morphogenetic protein-2 acts upstream of myocyte-specific enhancer factor 2a to control embryonic cardiac contractility. , 2007, Cardiovascular research.
[2] S. Glassman,et al. Clinical Outcomes and Fusion Success at 2 Years of Single-Level Instrumented Posterolateral Fusions With Recombinant Human Bone Morphogenetic Protein-2/Compression Resistant Matrix Versus Iliac Crest Bone Graft , 2006, Spine.
[3] K. Bulsara,et al. Safety of transforaminal lumbar interbody fusion and intervertebral recombinant human bone morphogenetic protein-2. , 2005, Journal of neurosurgery. Spine.
[4] Di Chen,et al. Bone Morphogenetic Proteins , 2004, Growth factors.
[5] B. Egbert,et al. Development of a Novel Nonantigenic Dermal Implant Composed of Human Placental Collagen , 2004, Plastic and reconstructive surgery.
[6] B. Chandrasekar,et al. BMP‐2 regulates cardiomyocyte contractility in a phosphatidylinositol 3 kinase‐dependent manner , 2003, FEBS letters.
[7] N. Wright,et al. Bone morphogenetic proteins and spinal fusion. , 2002, Neurosurgical focus.
[8] C. Dickman,et al. Anterior Lumbar Interbody Fusion Using rhBMP-2 With Tapered Interbody Cages , 2002, Journal of spinal disorders & techniques.
[9] J. Lane,et al. Safety Profile for the Clinical Use of Bone Morphogenetic Proteins in the Spine , 2002, Spine.
[10] H. Sandhu,et al. Use of Recombinant Human Bone Morphogenetic Protein-2 in Spinal Fusion Applications , 2002, Spine.
[11] Safdar N. Khan,et al. Bone morphogenetic proteins: relevance in spine surgery. , 2002, The Orthopedic clinics of North America.
[12] G. Zych,et al. Osteogenic Protein-1 (Bone Morphogenetic Protein-7) in the Treatment of Tibial Nonunions: A Prospective, Randomized Clinical Trial Comparing rhOP-1 with Fresh Bone Autograft* , 2001, The Journal of bone and joint surgery. American volume.
[13] S. Boden,et al. The Use of rhBMP-2 in Interbody Fusion Cages: Definitive Evidence of Osteoinduction in Humans: A Preliminary Report , 2000, Spine.
[14] G. Charriere,et al. Bovine collagen induced systemic symptoms: antibody formation against bovine and human collagen. , 1996, The Journal of rheumatology.
[15] F. Delustro,et al. Clinical use of injectable bovine collagen: a decade of experience. , 1992, Clinical materials.
[16] J. Dasch,et al. Immune responses to allogeneic and xenogeneic implants of collagen and collagen derivatives. , 1990, Clinical orthopaedics and related research.
[17] J. McPherson,et al. The human immune response to reconstituted bovine collagen. , 1986, Journal of immunology.
[18] N. Swanson,et al. Intradermal implantation of bovine collagen. Humoral immune responses associated with clinical reactions. , 1984, Archives of dermatology.
[19] L Cooperman,et al. The immunogenicity of injectable collagen. I. A 1-year prospective study. , 1984, Journal of the American Academy of Dermatology.
[20] L. Cooperman,et al. The immunogenicity of injectable collagen. II. A retrospective review of seventy-two tested and treated patients. , 1984, Journal of the American Academy of Dermatology.